Myo-Inositol is a longevity product whose active basis is insulin second-messenger. Improves insulin sensitivity and menstrual regularity. It is positioned for resale to the growing healthspan-focused consumer market.
Counters insulin resistance, a metabolic aging driver. Research relevant to this mechanism is indexed on PubMed and linked below; it describes the mechanism rather than this specific product.
Peer-reviewed studies on the active compound — citations link to PubMed.
“Inositol is an effective and safe treatment in PCOS”
“myoinositol acts as an insulin sensitizer and exerts beneficial effects in PCOS”
“The insulin sensitivity improved in both treatment groups”
Research describes the active mechanism and is not a claim about this specific product.
Slightly reduces coronary mortality and events. Research relevant to this mechanism is…
Counters sarcopenia, frailty and bone loss in aging. Research relevant to this mechanism…
Counters oxidative stress accumulating with age. Research relevant to this mechanism is…
Maintains immune competence across the lifespan. Research relevant to this mechanism is…
Yes — its active compound is linked to 3 peer-reviewed studies, summarized and cited above.
You can buy it on Amazon via the link above; Magellan earns a small affiliate commission at no extra cost to you, which does not affect the evidence grade.
Dietary supplements and devices are generally well tolerated but are not a substitute for medical care. Talk to your physician before starting, especially if you take medication or have a health condition.